Ioana R Preston

15PUBLICATIONS
54CO-AUTHORS
Cell physiologyRespiratory diseasesPharmacogenomicsToxicology (incl. clinical toxicology)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 10, 2026
Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension.

|Jul 28, 2026
Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.

|Apr 21, 2025
A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension.

Daniel J Strick, Carl Tanba, Meredith A Kaplan

|Apr 01, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.

Marc Humbert, Vallerie V McLaughlin, David B Badesch

|Feb 20, 2025
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA.

Ioana R Preston, David Badesch, Hossein-Ardeschir Ghofrani

|Jan 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.

Marius M Hoeper, Mardi Gomberg-Maitland, David B Badesch

Pageof 3

Frequent Collaborators

6 joint publications

Rogerio Souza

5 joint publications

Marius M Hoeper

4 joint publications

Marc Humbert

4 joint publications

Aaron B Waxman